Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 1, 2014, Pages 100-108

  Modh, Rahul P ^a   De Clercq, Erik ^b   Pannecouque, Christophe ^b   Chikhalia, Kishor H ^a  

^a GUJARAT UNIVERSITY   (India)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Anti HIV; Antimicrobial; Diaryl triazine (DATA); Dibromo quinazoline; Piperazine

Indexed keywords

ANTHRANILIC ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CHLORINE DERIVATIVE; CYANURIC CHLORIDE; ETHYLENEDIAMINE; QUINAZOLINE; QUINAZOLINE TRIAZINE DERIVATIVE; TRIAZINE; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASPERGILLUS CLAVATUS; BACILLUS CEREUS; BIOASSAY; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HYBRIDIZATION; IN VITRO STUDY; INFRARED SPECTROMETRY; KLEBSIELLA PNEUMONIAE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SUBSTITUTION REACTION; VIRUS STRAIN;

ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; DRUG DESIGN; QUINAZOLINES; TRIAZINES;

EID: 84887495816     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.755622     Document Type: Article

References (51)

1. UNAIDS 2011 World AIDS Day report. Available from: Http:// www.unaids.org. [last accessed 30 Oct 2012
2. Ragno R, Frasca S, Manetti F, et al. HIV-reverse transcriptase inhibition: Inclusion of ligand-induced fit by cross-docking studies. J Med Chem 2004;48:200-12
3. Hirschel B, Francioli P. Progress and problems in the fight against AIDS. N Engl J Med 1998;338:906-8
4. De Clercq E. New developments in anti-HIV chemotherapy. Curr Med Chem 2001;8:1543-72
5. Das K, Clark AD, Lewi PJ, et al. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-Type and drug-resistant HIV-1 variants. J Med Chem 2004;47:2550-60
6. Muregi FW, Ishih A. Next-generation antimalarial drugs: Hybrid molecules as a new strategy in drug design. Drug Develop Res 2010;71:20-32
7. Zhou C, Min J, Liu Z, et al. Synthesis and biological evaluation of novel 1,3,5-Triazine derivatives as antimicrobial agents. Bioorg Med Chem Lett 2008;18:1308-11
8. Srinivas K, Srinivas U, Bhanuprakash K, et al. Synthesis and antibacterial activity of various substituted s-Triazines. Eur J Med Chem 2006;41:1240-6
9. Modh RP, Patel AC, Mahajan DH, et al. Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents. Arch Pharm 2012;345:964-72
10. Kaswala PB, Chikhalia KH, Shah NK, et al. Design, synthesis and antimicrobial evaluation of s-Triazinyl urea and thiourea derivatives. Arkivoc 2009;11:326-35
11. Machakanur SS, Patil BR, Pathan AH, et al. Synthesis, antimicrobial and antimycobacterial evaluation of star shaped hydrazones derived from 1,3,5-Triazine. Der Pharma Chemica 2012;4:600-7
12. Menicagli R, Samaritani S, Signore G, et al. In vitro cytotoxic activities of 2-Alkyl-4,6-diheteroalkyl-1,3,5-Triazines: New molecules in anticancer research. J Med Chem 2004;47:4649-52
13. Garaj V, Puccetti L, Fasolis G, et al. Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-Triazine moieties as inhibitors of the cytosolic and tumour-Associated carbonic anhydrase isozymes I, II and IX. Bioorg Med Chem Lett 2005;15:3102-8
14. Melato S, Prosperi D, Coghi P, et al. A combinatorial approach to 2,4,6-Trisubstituted triazines with potent antimalarial activity: Combining conventional synthesis and microwave-Assistance. ChemMedChem 2008;3:873-6
15. Xiong YZ, Chen FE, Balzarini J, et al. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: Structural modulations of diaryltriazines with potent anti-HIV activity. Eur J Med Chem 2008;43:1230-6
16. Bartroli J, Turmo E, Algueró M, et al. New azole antifungals. 3. synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones1,2. J Med Chem 1998;41:1869-82
17. El-Sharief A, Ammar Y, Zahran M, et al. Aminoacids in the synthesis of heterocyclic systems: The synthesis of triazinoquinazolinones, triazepinoquinazolinones and triazocinoquinazolinones of potential biological interest. Molecules 2001;6:267-78
18. Modh RP, Patel AC, Chikhalia KH. Design, synthesis biological evaluation of some novel quinazolinone scaffolds. Med Chem 2012;8:182-92
19. Purohit DM, Bhuva VR, Shah VH. Synthesis of 5-Arylaminosulpho-N- Acetylanthranilic acid, 6-Arylaminosulpho-2-methyl-3-Amino/3-Nchloroacetamido/ 3-N-Arylaminoacetamido-4-(3H)-quinazolones as potential anti-HIV, anticancer and antimicrobial agents. Chem Indian J 2003;1:233-45
20. Wang Z, Wang M, Yao X, et al. Design, synthesis and antiviral activity of novel quinazolinones. Eur J Med Chem 2012;53:275-82
21. Murav'eva KM, Arkhangel'skaya NV, Shchukina MN, et al. Synthesis and tuberculostatic activity of aminoquinazoline derivatives. Pharm Chem J 1971;5:339-41
22. Barker (ZENECA Limited) AJ, inventor; Quinazoline derivatives and their use as anti-cancer agents, European patent EP 0635498; 1995
23. Laddha SS, Bhatnagar SP. A new therapeutic approach in Parkinson's disease: Some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents. Bioorg Med Chem 2009;17:6796-802
24. Aziza MA, Ibrahim MK, El-Helpy AG. Part II. Synthesis of novel-2-styryl-3-benzylidenimino-4(3H)-quinazolone derivatives of expected anticonvulsant activity. Al-Azhar J Pharm Sci 1994; 14:193-201
25. Jatav V, Mishra P, Kashaw S, Stables JP. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-Thiadiazole-2-yl] -2-styryl quinazoline-4(3H)-ones. Eur J Med Chem 2008;43:1945-54
26. Kurogi Y, Inoue Y, Tsutsumi K, et al. Synthesis and hypolipidemic activities of novel 2-[4-[(diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones. J Med Chem 1996;39:1433-7
27. Terashima K, Shimamura H, Kawase A, et al. Studies on antiulcer agents. IV: Antiulcer effects of 2-benzylthio-5, 6, 7, 8-Tetrahydro-4 (3H)-quinazolinones and related compounds. Chem Pharm Bull 1995;43:2021-3
28. Alagarsamy V, Raja Solomon V, Dhanabal K. Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3Hquinazolin-4-one as analgesic, anti-inflammatory agents. Bioorg Med Chem 2007;15:235-41
29. Nawrocka W, Zimecki M. Syntheses of Novel 3-Amino-2(1H)-Thioxo-4(3H)- quinazolinones and evaluation of their immunotropic activity. Part III. Arch Pharm 1997;330:399-405
30. Upadhayaya RS, Vandavasi JK, Kardile RA, et al. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents. Eur J Med Chem 2010;45:1854-67
31. Al-Turkistani AA, Al-Deeb OA, El-Brollosy NR,El-Emam AA. Synthesis and antimicrobial activity of some novel 5-Alkyl-6-substituted uracils and related derivatives. Molecules 2011;16:4764-74
32. Ananda Kumar C, Vinaya K, Narendra Sharath Chandra J, et al. Synthesis and antimicrobial studies of novel 1-benzhydryl-piperazine sulfonamide and carboxamide derivatives. J Enzyme Inhib Med Chem 2008;23:462-9
33. Upadhayaya RS, Sinha N, Jain S, et al. Optically active antifungal azoles: Synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3- (5-{2-[4-Aryl-piperazin-1-yl]-ethyl}-Tetrazol-2-yl/1-yl)-1-[1,2,4] -Triazol-1-yl-butan-2-ol. Bioorg Med Chem 2004;12:2225-38
34. Banerjee D, Yogeeswari P, Bhat P, et al. Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. Eur J Med Chem 2011;46:106-21
35. Singh KK, Joshi SC, Mathela CS. Synthesis and in vitro antibacterial activity of N-Alkyl and N-Aryl piperazine derivatives. Indian J Chem B 2011;50:196
36. Kerns RJ, Rybak MJ, Kaatz GW, et al. Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus. Bioorg Med Chem Lett 2003;13:2109-12
37. Patel RV, Kumari P, Rajani DP, et al. Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-Triazine-based heterocycles. Future Med Chem 2012;4:1053-65
38. Patel RB, Desai KR, Chikhalia KH. Synthesis and studies of novel homoveratryl based thiohydantoins as antibacterial as well as anti-HIV agents. Indian J Chem B 2006;45B:1716
39. Patel RB, Chikhalia KH, Pannecouque C, Clercq E. Synthesis of novel PETT analogues: 3, 4-dimethoxy phenyl ethyl 1, 3, 5-Triazinyl thiourea derivatives and their antibacterial and anti-HIV studies. J Braz Chem Soc 2007;18:312-21
40. Patel RB, Chikhalia KH. Synthesis of heterocyclic and nonheterocyclic entities as antibacterial and anti-HIV agents. Indian J Chem B 2006;45B:1871
41. Mahajan DH, Pannecouque C, De Clercq E, Chikhalia KH. Synthesis and studies of new 2-(coumarin-4-yloxy)-4, 6-(substituted)-s-Triazine derivatives as potential anti-HIV agents. Arch Pharm 2009;342:281-90
42. Desai SD, Desai KR, Chikhalia KH, et al. Synthesis of a novel class of some 1, 3, 5-Triazine derivatives and their anti-HIV activity. Int J Drug Des Dis 2011;2:361-8
43. Chen X, Zhan P, Liu X, et al. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-Triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 2012;20:3856-64
44. Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-Transcriptase inhibitor abacavir. Lancet 2002; 359:727-32
45. Mutlib A, Chen H, Shockcor J, et al. Characterization of novel glutathione adducts of a non-nucleoside reverse transcriptase inhibitor, (s)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-3,4-dihydro-2(1h) -quinazolinone (dpc 961), in rats. possible formation of an oxirene metabolic intermediate from a disubstituted alkyne. Chem Res Toxicol 2000;13:775-84
46. Hawkey P, Lewis DA. Medical bacteriology: A practical approach. Oxford, UK: Oxford University Press; 2004
47. Baba M, Snoeck R, Pauwels R, De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, human immunodeficiency virus. Antimicrob Agents Chemother 1988;32:1742-5
48. Pannecouque C, Daelemans D, De Clercq E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: Revisited 20 years later. Nat Protoc 2008;3:427-34
49. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497-500
50. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220:868-71
51. Miyoshi I, Taguchi H, Kubonishi I, et al. Type C virus-producing cell lines derived from adult T cell leukemia. Gann Monogr 1982;28:219-28